The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545

Neutrophil Emigration in the Skin, Lungs, and Peritoneum: Different Requirements for CD11/CD18 Revealed by CD18-deficient Mice

Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677

Clinical and immunological features of severe and moderate coronavirus disease 2019

Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750

An endotoxin-induced serum factor that causes necrosis of tumors

Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532

Coronaviruses: An Overview of Their Replication and Pathogenesis

Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910

The reproductive number of COVID-19 is higher compared to SARS coronavirus

Liu, Y., Gayle, A. A., Wilder‐Smith, A., & Rocklöv, J. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa021 · Cited by 3,243

Hydroxypropyl-beta-cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication and virus-induced inflammatory cytokines

Bezerra, B. B., da Silva, G. P. D., Coelho, S. V. A., Corrêa, I. A., de Souza, M. R. M., Macedo, K. V. G., Matos, B. M., Tanuri, A., Matassoli, F. L., da Costa, L. J., et al. (2022) · Antiviral Research · doi:10.1016/j.antiviral.2022.105373 · Cited by 26

Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review

Gianni, P., Goldin, M., Ngu, S., Zafeiropoulos, S., Geropoulos, G., & Giannis, D. (2022) · World Journal of Experimental Medicine · doi:10.5493/wjem.v12.i4.53 · Cited by 26

Low molecular weight cytotoxic components (DAMPs) form the post-COVID-19 syndrome

Klimova, E. M., Божков, А. И., Lavinska, O. V., Drozdova, L. A., & Kurhuzova, N. I. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152316 · Cited by 26

Discovery and pharmacophoric characterization of chemokine network inhibitors using phage-display, saturation mutagenesis and computational modelling

Vales, S., Kryukova, J., Chandra, S., Smagurauskaite, G., Payne, M., Clark, C. J., Hafner, K., Mburu, P., Denisov, S. S., Davies, G., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41488-z · Cited by 27

BRD4 targeting nanotherapy prevents lipopolysaccharide induced acute respiratory distress syndrome

Pooladanda, V., Thatikonda, S., Muvvala, S. P., Devabattula, G., & Godugu, C. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120536 · Cited by 26

Immunomodulatory Effects of Vitamin D and Zinc on Viral Infection

Rizwan, M., Cheng, K., Gang, Y., Hou, Y., & Wang, C. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04139-y · Cited by 25

The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future

Zhang, J., Wang, M., Ding, W., & Wan, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118142 · Cited by 25

Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein

Rizzi, M., Costanzo, M., Tonello, S., Matino, E., Casciaro, G. F., Croce, A., Rizzi, E., Zecca, E., Pedrinelli, A. R., Vassia, V., et al. (2022) · Disease Markers · doi:10.1155/2022/3528312 · Cited by 25

Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern

Murer, L., Volle, R., Andriasyan, V., Petkidis, A., Gómez-González, A., Yang, L., Meili, N., Suomalainen, M., Bauer, M., Sequeira, D. P., et al. (2022) · Current Research in Virological Science · doi:10.1016/j.crviro.2022.100019 · Cited by 25

The Efficacy of Traditional Medicinal Plants in Modulating the Main Protease of SARS‐CoV‐2 and Cytokine Storm

Choe, J., Yong, P. H., & Ng, Z. X. (2022) · Chemistry & Biodiversity · doi:10.1002/cbdv.202200655 · Cited by 25

The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness

Keikha, R., Hashemi‐Shahri, S. M., & Jebali, A. (2023) · Neurología (English Edition) · doi:10.1016/j.nrleng.2023.05.002 · Cited by 25

The role of lovastatin in the attenuation of COVID-19

Karampoor, S., Hesamizadeh, K., Shams, Z., Novin, A. G., Farahmand, M., Zahednasab, H., Mirzaei, R., Zamani, F., Hajibaba, M., Bouzari, B., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108192 · Cited by 25

Consensus Clinical Guidance for Diagnosis and Management of Adult COVID-19 Encephalopathy Patients

Michael, B. D., Walton, D., Westenberg, E., García‐Azorín, D., Singh, B., Tamborska, A., Netravathi, M., Chomba, M., Wood, G. K., Easton, A., et al. (2021) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.22010002 · Cited by 26

Managing diabetic foot in times of COVID-19: time to put the best ‘foot’ forward

Atri, A., Kocherlakota, C., & Dasgupta, R. (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00866-9 · Cited by 24

Does endometriosis increase susceptibility to COVID-19 infections? A case–control study in women of reproductive age

Moazzami, B., Chaichian, S., Samie, S., Zolbin, M. M., Jesmi, F., Akhlaghdoust, M., Pishkuhi, M. A., Mirshafiei, Z. S., Khalilzadeh, F., & Safari, D. (2021) · BMC Women s Health · doi:10.1186/s12905-021-01270-z · Cited by 24

Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients

Gradin, A., Andersson, H., Luther, T., Anderberg, S. B., Rubertsson, S., Lipcsey, M., Åberg, M., Larsson, A. O., Frithiof, R., & Hultström, M. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155589 · Cited by 25

Prediction of mortality in hospitalized Egyptian patients with Coronavirus disease-2019: A multicenter retrospective study

Abdelghaffar, M. M., Omran, D., Elgebaly, A. S., Bahbah, E. I., Afify, S., Alsoda, M. F., El‐Shiekh, M., Elsayed, E. S. M., Shaaban, S. S., Abdel-Hafez, S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262348 · Cited by 24

New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts

Wang, B., Li, D., Fiselier, A., Kovalchuk, I., & Kovalchuk, O. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00876-y · Cited by 25

Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives

Yao, W., Shi, L., Zhang, Y., Dong, H., & Zhang, Y. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02810-6 · Cited by 24

In silico Study of Some Dexamethasone Analogs and Derivatives against SARs-CoV-2 Target: A Cost-effective Alternative to Remdesivir for Various COVID Phases

Pandey, R., Dubey, I., Ahmad, I., Mahapatra, D. K., Patel, H., & Kumar, P. (2022) · Current Chinese Science · doi:10.2174/2210298102666220404102217 · Cited by 24

Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses

Venkataraman, S. (2022) · Vaccines · doi:10.3390/vaccines10111805 · Cited by 24

Nanotechnology and COVID-19: Prevention, diagnosis, vaccine, and treatment strategies

Ayan, S., Aranci, K., Çiftçi, F., & Üstündağ, C. B. (2023) · Frontiers in Materials · doi:10.3389/fmats.2022.1059184 · Cited by 24

Multifaceted Nature of Lipid Droplets in Viral Interactions and Pathogenesis

Huitron, L. H.-M., Jesús‐González, L. A. D., Castillo, M. M., Ulloa-Aguilar, J. M., Cabello-Gutiérrez, C., Helguera‐Repetto, A. C., García‐Cordero, J., & León‐Juárez, M. (2023) · Microorganisms · doi:10.3390/microorganisms11071851 · Cited by 24

Obesity-Related Inflammation and Endothelial Dysfunction in COVID-19: Impact on Disease Severity

Lorenzo, A. D., Estato, V., Castro-Faria-Neto, H. C., & Tibiriçá, E. V. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s282710 · Cited by 24

Mitochondria at the Crossroads of Physiology and Pathology

Moro, L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061971 · Cited by 25

Long COVID-19: Psychological symptoms in COVID-19 and probiotics as an adjunct therapy

Thye, A. Y.-K., Tan, L. T., Law, J. W., Pusparajah, P., & Letchumanan, V. (2022) · Progress In Microbes & Molecular Biology · doi:10.36877/pmmb.a0000267 · Cited by 24

Ocular manifestations of COVID-19

Ng, H., Scott, D. A. R., Danesh-Meyer, H. V., Smith, J. R., McGhee, C. N. J., & Niederer, R. L. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101285 · Cited by 25

Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2

Kohan, H. G., & Jamali, F. (2020) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps31346 · Cited by 23

An integrative look at SARS‑CoV‑2 (Review)

Ortega, M. A., Fraile‐Μartinez, O., Montero, C. G., García‐Gallego, S., Sánchez‐Trujillo, L., Torres‐Carranza, D., Álvarez-Mon, M. Á., Pekarek, L., García‐Honduvilla, N., Buján, J., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4828 · Cited by 24

Increased TLR/MyD88 signaling in patients with obesity: is there a link to COVID-19 disease severity?

Cuevas, A. M., Clark, J. M., & Potter, J. J. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00768-8 · Cited by 23

Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease

Singh, H., Singh, A., Khan, A. A., & Gupta, V. K. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105023 · Cited by 23

Efficacy of individualized homeopathy as an adjunct to standard of care of COVID-19: A randomized, single-blind, placebo-controlled study

Nayak, D., Gupta, J., Chaudhary, A., Singh, K. G., Deshmukh, A., Das, D., Saha, A., Kumar, D., Kumar, A., Goenka, A., et al. (2022) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2022.101602 · Cited by 23

The Impact of Meteorological Factors and Air Pollutants on Acute Coronary Syndrome

Rus, A.-A., & Mornoş, C. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01759-5 · Cited by 23

Role of neuroinflammation mediated potential alterations in adult neurogenesis as a factor for neuropsychiatric symptoms in Post-Acute COVID-19 syndrome—A narrative review

Karthik, S., Saraswathi, I., Alarifi, A., Al-Atram, A. A., Mickeymaray, S., Paramasivam, A., Shaikh, S., Jeraud, M., & Alothaim, A. S. (2022) · PeerJ · doi:10.7717/peerj.14227 · Cited by 23

LC-MS/MS: A sensitive and selective analytical technique to detect COVID-19 protein biomarkers in the early disease stage

Gajula, S. N. R., Khairnar, A. S., Jock, P., Kumari, N., Pratima, K., Munjal, V., Kalan, P., & Sonti, R. (2023) · Expert Review of Proteomics · doi:10.1080/14789450.2023.2191845 · Cited by 23

Telomere length, epidemiology and pathogenesis of severe COVID‐19

Tsilingiris, D., Tentolouris, A., Eleftheriadou, I., & Tentolouris, N. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13376 · Cited by 23

Cardiovascular Health and Disease in the Context of COVID-19

Umbrajkar, S., Stankowski, R. V., Rezkalla, S. H., & Kloner, R. A. (2021) · Cardiology Research · doi:10.14740/cr1199 · Cited by 23

CVD and COVID-19: Emerging Roles of Cardiac Fibroblasts and Myofibroblasts

Katwa, L. C., Mendoza, C., & Clements, M. (2022) · Cells · doi:10.3390/cells11081316 · Cited by 23

Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic

Noor, R. (2020) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_100_20 · Cited by 22

Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy

Barros, I., Silva, A., de Almeida, L. P., & Miranda, C. O. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.12.002 · Cited by 22

Potential Beneficial Effects of Vitamin K in SARS-CoV-2 Induced Vascular Disease?

Kudelko, M., Yip, T. F., Law, G. C. H., & Lee, S. M.-Y. (2021) · Immuno · doi:10.3390/immuno1010003 · Cited by 22

COVID‐19: a possible trigger for oral lichen planus?

Burgos‐Blasco, P., Fernández‐Nieto, D., Selda‐Enríquez, G., Melián-Olivera, A., de Perosanz-Lobo, D., Domínguez-Santás, M., & Alonso-Castro, L. (2021) · International Journal of Dermatology · doi:10.1111/ijd.15529 · Cited by 22

Effects of antiviral drug therapy on dynamic thiol/disulphide homeostasis and nitric oxide levels in COVID-19 patients

Mete, A. Ö., Koçak, K., Saracaloğlu, A., Demiryürek, Ş., Altınbaş, Ö., & Demiryürek, A. T. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174306 · Cited by 22

Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival

Gibellini, L., Biasi, S. D., Meschiari, M., Gozzi, L., Paolini, A., Borella, R., Mattioli, M., Tartaro, D. L., Fidanza, L., Neroni, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.842150 · Cited by 22

Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction

Lodge, S., Lawler, N. G., Gray, N., Masuda, R., Nitschke, P., Whiley, L., Bong, S.-H., Yeap, B. B., Dwivedi, G., Spraul, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411614 · Cited by 24

Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy?

Kazama, I. (2020) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2020.03046 · Cited by 22

Brain and COVID-19 Crosstalk: Pathophysiological and Psychological Manifestations

Verma, K., Amitabh, Prasad, D. N., Kumar, B., & Kohli, E. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00446 · Cited by 23

Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses In Vitro

Stone, N. E., Jaramillo, S. A., Jones, A. N., Vazquez, A. J., Martz, M., Versluis, L. M., Raniere, M. O., Nunnally, H. E., Zarn, K. E., Nottingham, R. D., et al. (2021) · mBio · doi:10.1128/mbio.03495-20 · Cited by 22

Chemokine Regulation During Epidemic Coronavirus Infection

Majumdar, S., & Murphy, P. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.600369 · Cited by 22

Vitamin D and COVID-19: is there a role?

Khan, A. H., Nasir, N., Nasir, N., Maha, Q., & Rehman, R. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00775-6 · Cited by 22

Feasibility, acceptability, and potential effectiveness of an online expressive writing intervention for COVID-19 resilience

Bechard, E. M., Evans, J., Cho, E., Lin, Y., Kozhumam, A. S., Jones, J. K., Grob, S. T., & Glass, O. (2021) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2021.101460 · Cited by 22

Multisystem Inflammatory Syndrome in Children and Adolescents (MIS-C) under the Setting of COVID-19: A Review of Clinical Presentation, Workup and Management

Farooq, A., Alam, F., Saeed, A., Butt, F., Khaliq, M. A., Malik, A. I., Chaudhry, M., & Abdullah, M. (2021) · Infectious Diseases Research and Treatment · doi:10.1177/11786337211026642 · Cited by 21

Zinc supplementation augments the suppressive effects of repurposed NF-κB inhibitors on ACE2 expression in human lung cell lines

Lee, M., Chen, Y., Tsai-Wu, J.-J., Hsu, Y., & Lin, B. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119752 · Cited by 21

Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review

Singh, E., Matada, G. S. P., Abbas, N., Dhiwar, P. S., Ghara, A., & Das, A. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00860-5 · Cited by 21

A new p65 isoform that bind the glucocorticoid hormone and is expressed in inflammation liver diseases and COVID-19

Spinelli, G., Biddeci, G., Artale, A., Valentino, F., Tarantino, G., Gallo, G., Gianguzza, F., Conaldi, P. G., Corrao, S., Gervasi, F., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-02119-z · Cited by 21

Ocular transmissibility of COVID-19: possibilities and perspectives

Davis, G., Li, K., Thankam, F. G., Wilson, D. R., & Agrawal, D. K. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04336-6 · Cited by 21

Risk factors of the severe course and fatal outcome in COVID-19

Sсherbak, S. G., Kamilova, Т. A., Голота, А. С., & Vologzhanin, D. A. (2022) · Physical and rehabilitation medicine medical rehabilitation · doi:10.36425/rehab104997 · Cited by 22

Endotracheal tube microbiome in hospitalized patients defined largely by hospital environment

Cifuentes, E. A., Sierra, M. A., Yepes, A., Baldión, A. M., Rojas, J. A., Álvarez, C., Anzola, J. M., Zambrano, M. M., & Huertas, M. G. (2022) · Respiratory Research · doi:10.1186/s12931-022-02086-7 · Cited by 22

Biological effects of COVID-19 on lung cancer: Can we drive our decisions

Aramini, B., Masciale, V., Samarelli, A., Tonelli, R., Cerri, S., Clini, E., Stella, F., & Dominici, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1029830 · Cited by 19

Overview of the Pathogenesis and Treatment of SARS-CoV-2 for Clinicians: A Comprehensive Literature Review

Voto, C., Berkner, P. D., & Brenner, C. A. (2020) · Cureus · doi:10.7759/cureus.10357 · Cited by 21

Cytokine-induced liver injury in coronavirus disease-2019 (COVID-19): untangling the knots

Anirvan, P., Narain, S., Hajizadeh, N., Aloor, F. Z., Singh, S. P., & Satapathy, S. K. (2021) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002034 · Cited by 22

Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain

Benedé‐Ubieto, R., Estévez‐Vázquez, O., Flores-Perojo, V., Macías‐Rodríguez, R. U., Ruiz‐Margáin, A., Martı́nez-Naves, E., Regueiro, J. R., Avila, M. A., Trautwein, C., Bañares, R., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051039 · Cited by 21

Potential mechanisms of action of convalescent plasma in COVID-19

Franchini, M., Glingani, C., & Liumbruno, G. M. (2021) · Diagnosis · doi:10.1515/dx-2020-0161 · Cited by 21

Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids

Fang, K., Cao, W.-C., Xie, T., Lv, J., Chen, J.-X., Cao, X., Li, Z.-W., Deng, S.-T., & Guo, X. (2021) · Human Genomics · doi:10.1186/s40246-021-00316-5 · Cited by 21

Gut bacteria, bacteriophages, and probiotics: Tripartite mutualism to quench the SARS-CoV2 storm

Zeinali, T., Faraji, N., Joukar, F., Mirzaei, M. K., Jalali, H. K., Shenagari, M., & Mansour-ghanaei, F. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105704 · Cited by 17

Targeting NLRP3 inflammasome in an animal model for Coronavirus Disease 2019 (COVID‐19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2)

Sergi, C. M., & Chiu, B. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26461 · Cited by 21

Perioperative melatonin in COVID-19 patients

Nair, A. S. (2022) · Medical Gas Research · doi:10.4103/2045-9912.325990 · Cited by 20

Interplay between Lung Diseases and Viral Infections: A Comprehensive Review

Suri, C., Pande, B., Sahithi, L. S., Sahu, T. A., & Verma, H. K. (2024) · Microorganisms · doi:10.3390/microorganisms12102030 · Cited by 20

Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?

Aricò, E., Bracci, L., Castiello, L., Gessani, S., & Belardelli, F. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.07.010 · Cited by 20

Murine-β-coronavirus-induced neuropathogenesis sheds light on CNS pathobiology of SARS-CoV2

Chakravarty, D., & Sarma, J. D. (2021) · Journal of NeuroVirology · doi:10.1007/s13365-021-00945-5 · Cited by 20

Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease

Srivastava, S. P., Srivastava, R., Chand, S., & Goodwin, J. E. (2021) · Pharmaceuticals · doi:10.3390/ph14080751 · Cited by 20

CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population

Kulmann‐Leal, B., Ellwanger, J. H., & Chies, J. A. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.758358 · Cited by 20

Infection risk with the use of interleukin inhibitors in hospitalized patients with COVID-19: A narrative review

Koritala, T., Pattan, V., Tirupathi, R., Rabaan, A. A., Mutair, A. S. A., Alhumaid, S., Adhikari, R., Deepika, K., Jain, N. K., Bansal, V., et al. (2021) · Infezioni in Medicina · doi:10.53854/liim-2904-1 · Cited by 20

Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment

Labandeira-García, J. L., Labandeira, C. M., Valenzuela, R., Pedrosa, M. A., Quijano, A., & Rodriguez-Perez, A. I. (2022) · Biomedicines · doi:10.3390/biomedicines10020502 · Cited by 20

Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression

Konwar, C., Asiimwe, R., Inkster, A. M., Merrill, S. M., Negri, G. L., Aristizabal, M. J., Rider, C. F., MacIsaac, J. L., Carlsten, C., & Kobor, M. S. (2021) · Epigenetics & Chromatin · doi:10.1186/s13072-021-00428-1 · Cited by 21

COVID-19 and systemic lupus erythematosus genetics: A balance between autoimmune disease risk and protection against infection

Wang, Y., Guga, S., Wu, K., Khaw, Z., Tzoumkas, K., Tombleson, P., Comeau, M. E., Langefeld, C. D., Graham, D. S. C., Morris, D. L., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010253 · Cited by 21

Endotoxin tolerance and low activation of TLR-4/NF-κB axis in monocytes of COVID-19 patients

Dorneles, G. P., Teixeira, P. C., Peres, A., Rodrigues, L. C., Fonseca, S. G., Monteiro, M. C., Eller, S. C. W. D. S., de Oliveira, T. F., Wendland, E., & Romão, P. R. T. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02283-x · Cited by 20

Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistance

O’Meara, T. R., Nanishi, E., McGrath, M. E., Barman, S., Dong, D., Dillen, C. A., Menon, M., Seo, H., Dhe‐Paganon, S., Ernst, R. K., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.06.031 · Cited by 20

Inflammatory markers are poorly predictive of clinical outcomes among hospitalized patients with COVID-19

Barrett, B. J., Pamphile, S., Yang, F., Naeem, F., Kim, J., Annam, J., Borczuk, R., Yellin, S., Bass, C., Fowler, S., et al. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.11.038 · Cited by 20

Ca2+ mishandling in heart failure: Potential targets

Val‐Blasco, A., Fernández, M. G., Rueda, A., Pereira, L., Delgado, C., Smani, T., Ruiz‐Hurtado, G., & Fernández‐Velasco, M. (2021) · Acta Physiologica · doi:10.1111/apha.13691 · Cited by 20

Neuroinflammation in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection: Pathogenesis and clinical manifestations

Cárdenas, G., Fragoso, G., & Sciutto, E. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.12.008 · Cited by 21

Can Panax ginseng help control cytokine storm in COVID-19?

Choi, J. H., Lee, Y. H., Kwon, T. W., Ko, S., Nah, S.-Y., & Cho, I. (2022) · Journal of Ginseng Research · doi:10.1016/j.jgr.2022.02.006 · Cited by 20

K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research

Dedoni, S., Avdoshina, V., Camoglio, C., Siddi, C., Fratta, W., Scherma, M., & Fadda, P. (2022) · Molecules · doi:10.3390/molecules27134142 · Cited by 20

Parallels in the Pathogenesis of SARS-CoV-2 and M. Tuberculosis : a synergistic or Antagonistic Alliance?

Tapela, K., Olwal, C. O., & Quaye, O. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0179 · Cited by 20

Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes

Dobosh, B., Zandi, K., Giraldo, D. M., Goh, S. L., Musall, K., Aldeco, M., LeCher, J., Giacalone, V. D., Yang, J., Eddins, D. J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110945 · Cited by 19

COVID-19 Disease, Women’s Predominant Non-Heparin Vaccine-Induced Thrombotic Thrombocytopenia and Kounis Syndrome: A Passepartout Cytokine Storm Interplay

Kounis, N. G., Koniari, I. C., GREGORIO, C. D., Assimakopoulos, S. F., Velissaris, D., Hung, M., Mplani, V., Saba, L., Brinia, A., Kouni, S. N., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9080959 · Cited by 19

The Chemokine CXCL7 Is Related to Angiogenesis and Associated With Poor Prognosis in Colorectal Cancer Patients

Li, L., Jiang, K., Li, D., Li, D., Fan, Z., Dai, G., Tu, S., Liu, X., & Wei, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.754221 · Cited by 19

Insights into potential mechanisms of asthma patients with COVID-19: A study based on the gene expression profiling of bronchoalveolar lavage fluid

Jiang, Y., Yan, Q., Liu, C., Peng, C.-W., Zheng, W., Zhuang, H., Huang, H.-T., Liu, Q., Liao, H., Zhan, S., et al. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105601 · Cited by 19

Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinations

Pugliatti, M., Berger, T., Hartung, H., Oreja‐Guevara, C., & Bar‐Or, A. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001066 · Cited by 19

Dual effects of supplemental oxygen on pulmonary infection, inflammatory lung injury, and neuromodulation in aging and COVID-19

Lin, M., Stewart, M. T., Zefi, S., Mateti, K. V., Gauthier, A. G., Sharma, B., Martinez, L. R., Ashby, C. R., & Mantell, L. L. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.08.004 · Cited by 20

Proteomic Analysis of Pleural Effusions from COVID-19 Deceased Patients: Enhanced Inflammatory Markers

Razaghi, A., Szakos, A., Alouda, M., Bozóky, B., Björnstedt, M., & Székely, L. (2022) · Diagnostics · doi:10.3390/diagnostics12112789 · Cited by 19

SARS-CoV-2 Nsp2 Contributes to Inflammation by Activating NF-κB

Lacasse, É., Gudimard, L., Dubuc, I., Gravel, A., Allaeys, I., Boilard, É., & Flamand, L. (2023) · Viruses · doi:10.3390/v15020334 · Cited by 19

Bioinformatics and system biology approach to identify the influences among COVID-19, ARDS and sepsis

Li, P., Li, T., Zhang, Z., Dai, X., Zeng, B., Li, Z., & Li, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1152186 · Cited by 19

Microbial natural compounds and secondary metabolites as Immunomodulators: A review

Mahmoudi, F., Jalayeri, M. H. T., Montaseri, A., Khosroshahi, L. M., & Baradaran, B. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134778 · Cited by 20

Clinical Course of Cancer Patients With COVID-19: A Retrospective Cohort Study

Alpert, N., Rapp, J. L., Marcellino, B. K., Lieberman‐Cribbin, W., Flores, R. M., & Taioli, E. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa085 · Cited by 19

Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis

Conti, V., Corbi, G., Sellitto, C., Sabbatino, F., Maci, C., Bertini, N., Bellis, E. D., Iuliano, A., Davinelli, S., Pagliano, P., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070628 · Cited by 19

Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19)

Ahmed, A. A., & Ad'hiah, A. H. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155702 · Cited by 19

Neurological pathophysiology of SARS‐CoV‐2 and pandemic potential RNA viruses: a comparative analysis

Chakravarty, N., Senthilnathan, T., Paiola, S. G., Gyani, P., Cario, S. C., Urena, E., Jeysankar, A., Jeysankar, P., Irudayam, J. I., Subramanian, S. N., et al. (2021) · FEBS Letters · doi:10.1002/1873-3468.14227 · Cited by 19

Chemokine receptor gene polymorphisms and COVID-19: Could knowledge gained from HIV/AIDS be important?

Mehlotra, R. K. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104512 · Cited by 18

Characteristics, outcomes and global trends of respiratory support in patients hospitalized with COVID-19 pneumonia: a scoping review

Radovanovic, D., Santus, P., Coppola, S., Saad, M., Pini, S., Giuliani, F., Mondoni, M., & Chiumello, D. (2021) · Minerva Anestesiologica · doi:10.23736/s0375-9393.21.15486-0 · Cited by 18

Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm

Pum, A., Ennemoser, M., Adage, T., & Kungl, A. J. (2021) · Biomolecules · doi:10.3390/biom11010091 · Cited by 89

The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved

Coperchini, F., Chiovato, L., Ricci, G., Croce, L., Magri, F., & Rotondi, M. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.12.005 · Cited by 135

Immune Profiling of COVID-19 in Correlation with SARS and MERS

Khalil, B. A., Shakartalla, S. B., Goel, S., Mdkhana, B., Halwani, R., Maghazachi, A. A., AlSafar, H. S., Al‐Omari, B., & Bataineh, M. T. A. (2022) · Viruses · doi:10.3390/v14010164 · Cited by 18

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections

Liu, T., Feng, M., Wen, Z., He, Y., Lin, W., & Zhang, M. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s329697 · Cited by 29

An enlightening role for cytokine storm in coronavirus infection

Zhao, Z., Wei, Y., & Tao, C. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108615 · Cited by 48